A carregar...
The mSHOX2 is capable of assessing the therapeutic effect and predicting the prognosis of stage IV lung cancer
BACKGROUND: Instant monitoring of the therapeutic effect of systematic therapy in late-stage lung cancer is crucial for response assessment and strategy adjustment. Previous study found that specific plasma methylation markers may be applied to therapeutic effect assessment. In order to investigate...
Na minha lista:
| Publicado no: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6626805/ https://ncbi.nlm.nih.gov/pubmed/31372283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.81 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|